Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular

Defining personalised medicine and patient empowerment

Prof Gabriella Pravettoni – University of Milan, Italy
Defining personalised medicine and patient empowerment ( Prof Gabriella Pravettoni – University of Milan, Italy )
4 Oct 2012

Phase I study examining PI 3 kinase inhibitor for various tumours

Dr Pamela Munster – University of California, San Francisco, USA
Phase I study examining PI 3 kinase inhibitor for various tumours ( Dr Pamela Munster – University of California, San Francisco, USA )
4 Oct 2012

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
30 Sep 2012

A proof-of-concept study of ODM-201 in patients with progressive castration-resistant prostate cancer

Dr Christophe Massard - Institute Gustave Roussy, Paris, France
A proof-of-concept study of ODM-201 in patients with progressive castration-resistant prostate cancer ( Dr Christophe Massard - Institute Gustave Roussy, Paris, France )
30 Sep 2012

Too few women being offered breast-conserving treatment?

Dr Carmen Criscitiello - European Institute of Oncology in Milan, Italy
Too few women being offered breast-conserving treatment? ( Dr Carmen Criscitiello - European Institute of Oncology in Milan, Italy )
30 Sep 2012

Awareness of personalised medicine in cancer patients

Dr Sabine Tejpar - University Hospital Gasthuisberg, Lueven, Belgium
Awareness of personalised medicine in cancer patients ( Dr Sabine Tejpar - University Hospital Gasthuisberg, Lueven, Belgium )
30 Sep 2012

Phase I and II trials focus on drug combination slowing development of resistance inhibiting BRAF

Prof Yossef Yarden - Weizmann Institute of Science, Israel.
Phase I and II trials focus on drug combination slowing development of resistance inhibiting BRAF ( Prof Yossef Yarden - Weizmann Institute of Science, Israel. )
29 Sep 2012

Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib

Dr Tony Mok - Chinese University of Hong Kong
Biomarker analysis of MISSION: EGFR lung tumours may benefit from sorafenib ( Dr Tony Mok - Chinese University of Hong Kong )
29 Sep 2012

Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III MISSION trial

Dr Luis Paz-Ares - Virgen del Rocio University Hospital in Seville, Spain
Sorafenib does not extend overall survival as third or fourth line therapy in lung cancer – Phase III MISSION trial ( Dr Luis Paz-Ares - Virgen del Rocio University Hospital in Seville, Spain )
29 Sep 2012

Highlights from the 17th International Conference on Cancer Nursing

Greta Cummings – President of the International Society of Nurses of Cancer Care
Highlights from the 17th International Conference on Cancer Nursing ( Greta Cummings – President of the International Society of Nurses of Cancer Care )
21 Sep 2012

Educational programmes for oncology nurses

Prof Mary Jane Esplen – University Health Network, Toronto, Canada
Educational programmes for oncology nurses ( Prof Mary Jane Esplen – University Health Network, Toronto, Canada )
21 Sep 2012

Oncology nursing and survivorship

Catherine Glennon – The University of Kansas Cancer Center, USA
Oncology nursing and survivorship ( Catherine Glennon – The University of Kansas Cancer Center, USA )
21 Sep 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation